folr1 car t-cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2025 (NCT06609928)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Folate receptor alphaImmunity, passive
FOLR1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07227571 | Phase 1 | May 1, 2026 | University of Washington |
| NCT06609928 | Phase 1 | Feb 1, 2025 | Kuni Foundation, University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Washington | Academic/Hospital | 2 | 2 | 1 | 2025 |
| Kuni Foundation | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1